#Pet Insurance Market Growth

[aarunresearcher]

United States pet insurance market size is projected to exhibit a growth rate (CAGR) of 10.80% during ​2024-2032​. 

[marketdevelopment]

Global Pet Insurance Market size was reasonably estimated to be approximately USD 8380.29 Million in 2023 and is poised to generate revenue over USD 18785.29 Million by the end of 2030, projecting a CAGR of around 17.52% from 2023 to 2030.

Pet Insurance Market Research Report 2023

[market-insider]

Germany Pet Insurance Market Growth Attributable To Increasing Prevalence Of Acute And Chronic Pet Health Diseases

The Germany pet insurance market size is anticipated to reach USD 2.65 billion by 2030, according to a new report by Grand View Research, Inc. The regional market is expected to expand at a CAGR of 14.6% from 2022 to 2030. The market growth is attributable to the increasing prevalence of acute and chronic pet health diseases, the rising humanization of pets, and supportive government regulations. For example, liability insurance is compulsory for certain dangerous dog breeds in the states of Saarland, Bremen, Hessen, Nordrhein-Westfalen, and Baden-Wurttemberg.

The COVID-19 outbreak catalyzed the market with a surge in pet adoption and pet health concerns. Wertgarantie Group, the parent company of Agila, reported an exponential rise in the purchase of dogs and cats in Germany in 2020, amid the pandemic. This positively affected the company’s pet health insurance business with about 340,000 new contracts. However, this number contrasted the 475,000 veterinary bills processed during the period for the benefit of customers.

Gain deeper insights on the market and receive your free copy with TOC now @: Germany Pet Insurance Market Report

As pet owners are becoming increasingly concerned about their pet’s health and wellbeing, the demand for pet insurance is expected to increase over time, due to high costs of treatment and surgery, awareness about pet health & diseases, and pet humanization. In addition, changing customer requirements, digitalization in the banking & insurance sectors, and the adoption of veterinary telehealth is estimated to fuel the market growth.

Intuitive pet insurance plans, quick checkouts, and offering online management of pet plans are some of the common features offered by fully digital insurance companies or Insurtech companies in the country. These trends are expected to continue during the forecast period. As per a 2018 survey by YouGov, the majority of Germans (around 52%) indicated a preference for managing their insurance contracts via online banking. The COVID-19 pandemic has further increased this preference.

Market players are involved in providing affordable and tailored insurance products to suit the needs and budgets of pet parents. These include monthly or annual plans, plans based on coverage type, and sold through various sales channels. Barmenia Insurance, for instance, offers horse surgery insurance that provides coverage from colic protection to premium surgery costs.

The company’s dog and cat health insurance plans come in 4 variants, wherein all plans cover operations, including partial anesthesia or local anesthesia with no annual maximum. Service additions to enhance product value is another unique selling point observed in the German pet insurance market. DFV Deutsche Familienversicherung AG, for example, partnered with FirstVet to offer veterinary telemedicine services to its animal health policyholders, thus expanding its offerings. 

[prajwal-agale001]

According to Meticulous Research®, the pet oral care market is set to reach $3 billion by 2030, growing at a CAGR of 6.1% during the forecast period. This growth is fueled by increasing pet ownership and population, rising pet expenditure and insurance, and the growing incidence of dental diseases in pets. The market is segmented by product types (such as toothpaste, toothbrushes, mouthwash, dental chews, and additives), animal type (dogs and cats), sales channels (including online platforms and offline stores like pet shops, supermarkets, and pharmacies), and geography. The study also assesses industry competitors and their market share on both global and regional scales.

[visionresearchreport]

The global veterinary oncology market was valued at approximately USD 1.22 billion in 2023 and is expected to reach around USD 3.56 billion by 2033, with a compound annual growth rate (CAGR) of 11.31% from 2024 to 2033. This market represents a fusion of advanced medical technology and dedicated care for our animal companions. As a crucial component of veterinary healthcare, it focuses on the diagnosis, treatment, and management of cancer across various animals, including pets and livestock.

The growing incidence of cancer among pets and the increasing acceptance of veterinary cancer treatments are major drivers of market expansion. Enhanced research and development in veterinary oncology, aimed at providing effective cancer treatments for pets, along with the rise of pet insurance, are also contributing to market growth. Notably, in July 2023, Ardent Animal Health joined forces with FidoCure to enhance access to oncology innovations in veterinary medicine through FidoCure's genomic testing and precision medicine platform.

[creativeera]

The Middle East and Africa Animal Healthcare Market is Poised for Exponential Growth driven by Rising Pet Ownership

The Middle East and Africa animal healthcare market comprises products such as vaccines, pharmaceuticals, and feed additives used for disease prevention and treatment in livestock animals. The demand for animal healthcare products is increasing due to rising awareness about zoonotic diseases and quality animal proteins. Advances in veterinary medicine and growth of the companion animal market have also fueled the demand for veterinary services and healthcare products in the region.

The Global Middle East and Africa Animal Healthcare Market is estimated to be valued at US$ 5478.77 Bn in 2024 and is expected to exhibit a CAGR of 14% over the forecast period 2024 To 2031. Key Takeaways Key players operating in the Middle East and Africa animal healthcare market are Siegfried, Sanofi, Johnson Matthey, Mallinckrodt, Noramco, Unichem Laboratories, Arevipharma GmbH, Resonance-labs, Sun Pharmaceutical Industries Ltd., Rusan Pharma, Micro Orgo Chem, and Faran Shimi Pharmaceutical Co. These companies are actively focusing on product innovations and expansion strategies to consolidate their market presence. The Middle East And Africa Animal Healthcare Market Demand for animal healthcare products is driven by rising pet ownership and growing consumption of animal-derived food products in the region. Various public and private organizations are undertaking initiatives to promote responsible pet ownership and prevent the spread of zoonotic diseases. Major animal healthcare companies are augmenting their production capacities and distribution networks across Middle Eastern and African countries. Strategic partnerships with local players help global companies to strengthen their supply chain and improve access to remote and rural areas. Collaboration with veterinary bodies and livestock industry associations also help gain consumer trust and market penetration. Market Key Trends The Middle East And Africa Animal Healthcare Market Size and Trends of pet humanization is contributing to the growth of the companion animal healthcare market in the region.Pet owners are increasingly spending more on nutritious pet food, grooming products, accessories, insurance, and advanced medical care. Growing pet obesity and lifestyle diseases have also increased the demand for therapeutic diet food and nutraceuticals for companion animals. E-commerce platforms are further facilitating the accessibility of diverse pet care products in the region.

Porter’s Analysis Threat of new entrants: High capital requirements and ongoing R&D investments of new drugs pose substantial barriers to entry. Bargaining power of buyers: Buyers have moderate bargaining power as there are many established brands to choose from. Bargaining power of suppliers: Suppliers of raw materials and components have moderate bargaining power due to differentiated inputs required. Threat of new substitutes: Threat of new substitutes is moderate as alternative treatment options are available in case of non-performance or high prices. Competitive rivalry: Intense competition exists among existing players to gain market share through product differentiation, marketing activities and competitive pricing. Geographical Regions The Middle East and Africa animal healthcare market in terms of value is currently concentrated in countries like Saudi Arabia, South Africa, and Egypt. Rapid urbanization and rising pet ownership are driving the demand for animal healthcare products in these countries. South Africa accounts for over 25% of the total market value in the region currently due to strong beef and dairy industries. The fastest growing geographical region for the Middle East and Africa animal healthcare market is expected to be West Africa over the forecast period 2024 to 2031. Countries like Nigeria, Ghana, and Ivory Coast are projected to witness double-digit growth rates during this period led by rising livestock production, increasing awareness about animal diseases, and growing veterinary healthcare infrastructure in the region. Economic development and changing diets are supporting the expansion of the livestock sector which is supporting the animal healthcare market growth.

Get more insights on Middle East And Africa Animal Healthcare Market

Unlock More Insights—Explore the Report in the Language You Prefer

French

German

Italian

Russian

Japanese

Chinese

Korean

Portuguese

Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.

(LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91)

[tamanna31]

Veterinary Orthopedic Medicines Market Poised for Steady Growth in the Future

Veterinary Orthopedic Medicines Industry Overview

The global veterinary orthopedic medicines market size was estimated at USD 1.62 billion in 2023 and is expected to grow at a CAGR of 8.6% from 2024 to 2030.

The growth can be attributed to rising prevalence of orthopedic disorders in animals, the growing uptake of pet insurance, an increase in the aging animal population, and advancements in veterinary orthopedic medicines. Orthopedic issues can negatively impact an animal's quality of life by affecting the bones, muscles, and joints. Canine dysplasia of the elbow & hips and arthritis are among common conditions. Several factors contribute to orthopedic problems in animals, including aging, poor diet, and obesity. Recent studies have shown a rise in obesity among animals such as dogs and horses. For instance, an NCBI study in 2023 on horses revealed a 45% obesity rate.

Gather more insights about the market drivers, restrains and growth of the Veterinary Orthopedic Medicines Market

Stem cell therapy has recently gained popularity and generated significant interest in research & clinical settings. In veterinary medicine, stem cell therapy has been studied as a potential treatment option for various health complications such as dermatological, orthopedic, dental, etc. The use of stem cells in these diseases is still in its infancy, but the potential for stem cell therapy in veterinary medicine is extensive. For instance, StemcellX, a UK-based company, currently has two stem-cell products in the pipeline for application in dogs and horses. The veterinary orthopedic medicines market is growing due to increase in prevalence of Osteoarthritis (OA) and other Degenerative Joint Diseases (DJD) among various animals like dogs, cats, & horses, among others. According to estimates from a 2022 study in Frontiers of Veterinary Sciences, OA is the most common musculoskeletal disorder in dogs, and about 1 in 4 dogs suffer from it. Another research study from the Veterinary Ireland Journal stated that approximately 40% of all cats suffer from OA. Estimates provided by the American Animal Hospital Association (AAHA) reveal that 40% to 92% of cats experience joint pain due to OA or other DJD. Furthermore, the studies suggest possible underdiagnosis of these conditions in these animals. Figures provided by Zoetis indicate that out of the total diagnosed cases of canine OA in the US, only 33% are treated.

Furthermore, University of Illinois data suggests that athletic horses are at a high risk of developing OA that causes lameness. It is estimated that over 50% of horses older than 15 years suffer from OA, and in horses over 30 years of age, this number increases to more than 80% to 90%. OA affects the performance and wellbeing of athletic horses. For early diagnosis, it is important to understand causal & developmental pathways and prescribe the right treatment. Moreover, several pet owners are opting for pet insurance to manage the health expenses of their pets. According to a February 2024 article in USA Today, 26% of surveyed Americans stated they spend between USD 51 & USD 100 a month on their dogs. The same number of people (26%) spend from USD 101 to USD 250 monthly on dog care. Ownership of a dog can cost up to USD 5,000 in some cases. About 66% of the respondents said they had to cut down on their personal expenses to meet the rising costs of owning a pet. Others have taken out loans or asked for financial assistance to pay for the care of animals.

Browse through Grand View Research's Animal Health Industry Research Reports.

The global livestock monitoring market size was estimated at USD 4.01 billion in 2023 and is anticipated to grow at a CAGR of 11.56% from 2024 to 2030. 

The North America and Europe exotic companion animal market size was estimated at USD 1.30 billion in 2023 and is projected to grow at a CAGR of 7.9% from 2024 to 2030.

Key Veterinary Orthopedic Medicines Company Insights

Some of the key players operating in the market are Zoetis Inc; Boehringer Ingelheim; Elanco Animal Health, Inc.; and Merck Animal Health (Merck & Co. Inc). Industry leaders like Zoetis, Inc.; Boehringer Ingelheim; Elanco Animal Health; American Regent, Inc.; Merck Animal Health (Merck & Co. Inc); and Vetoquinol S.A. are investing significantly in the R&D of novel medicines for musculoskeletal complications prevalent in various animals. Companies like Ardent Animal Health, LLC; VetStem, Inc.; and MEDREGO LLC are focusing on developing specialized biologics like stem cells, PRP, and other biologics to effectively combat orthopedic conditions in animals.

Zoetis is one of the leading veterinary product companies in the world. It discovers, develops, manufactures, and commercializes vaccines, medicines, diagnostics, & other technologies for the treatment of various diseases in companion animals, as well as livestock animals. It has a widespread network in over 45 countries.

Elanco Animal Health has operated in the veterinary industry for over 65 years. It is a subsidiary of the pharmaceutical products giant Elli Lilly & Company. The company is among the top four global veterinary product manufacturers, with over 200 brands and a presence in over 90 countries.

Hyalogic, Bioiberica S.A.U, and Contipro A.S. are some of the emerging market participants in the veterinary orthopedic medicines market.

Hyalogic is a company that specializes in and focuses on manufacturing products made from high-molecular-weight hyaluronic acid, which has hydrating and lubricating properties. Its product portfolio includes skin care, personal care, joint care, etc., for humans and specialized joint care products for animals.

Key Veterinary Orthopedic Medicines Companies:

The following are the leading companies in the veterinary orthopedic medicines market. These companies collectively hold the largest market share and dictate industry trends.

Zoetis Inc.

Boehringer Ingelheim

Elanco Animal Health

American Regent, Inc.

Merck Animal Health (Merck & Co. Inc)

Vetoquinol S.A.

Ceva Sante Animale

Virbac

Biogenesis Bago

Ardent Animal Health, LLC

Bioiberica S.A.U

PetVivo Holdings, Inc. (Spryng)

Contipro A.S.

VetStem, Inc.

Enso Discoveries

Contura Vet US

T-Cyte Therepeutics

MEDREGO LLC

Bimeda U.S.

Hyalogic

Hester Biosciences .

Order a free sample PDF of the Veterinary Orthopedic Medicines Market Study, published by Grand View Research.

[industrynewsupdates]

A Comprehensive Guide to Medical Coveralls Procurement Intelligence

The global medical coveralls category is anticipated to grow at a CAGR of 7.4% from 2023 to 2030. The most important PPE in the world was the hooded disposable coveralls in 2020 - 2021. Due to the COVID-19 pandemic, there has been an increase in demand for disposable protective coveralls/apparel because of heightened awareness of self-protection. On a parent level, the PPE category is experiencing tremendous growth due to its industry-agnostic nature and varied applications. The growth of the category is being driven by emerging diseases, such as the September 2022 Ebola outbreak in Uganda and the SARS, new Omicron, and flu variants worldwide. This has increased the need for protection for frontline healthcare workers. All such factors are boosting the demand for medical coveralls globally.

Disposable protective coveralls can be categorized into various levels based on their strength of protection such as - Categories I (minimal risk), II (medium risk), and III (complex PPE). According to EU standards, the medical coveralls can be classified into different types - Type 1, 2, 3, 4, 5, and 6. The compliance requirements for types 1 to 4 include EN 14605 and EN 13982-1 for types 5 and 6. With advancements in technology, compliance requirements also play a key role. Over the years, medical coveralls have evolved from being basic garments into technologically advanced protective gear. As a result of technological advancements, coverall fabrics have also been designed to contain antimicrobial properties. Nanotechnology enabled the creation of nanoparticles embedded in coverall fibers for added protection. The latest medical coverall technology involves ‘smart’ coveralls with built-in sensors to monitor vital signs and alert healthcare professionals of any anomalies.

The medical coveralls category is highly fragmented. The top fifteen to twenty players account for a nominal share of the market. The major players in this category include raw-material suppliers, PPE divisions of major conglomerates, pure-play PPE/medical coveralls manufacturers, and wholesale and retail distributors. Within each segment again, the dynamics vary, which further reduces the bargaining power of suppliers. Manufacturers of coveralls are constantly trying to innovate by employing different types of materials. One instance is the use of SMS fabrics. These fabrics can withstand liquid while being available at competitive prices.

Order your copy of the Medical Coveralls Procurement Intelligence Report, 2023 - 2030, published by Grand View Research, to get more details regarding day one, quick wins, portfolio analysis, key negotiation strategies of key suppliers, and low-cost/best-cost sourcing analysis

The major cost components in the medical coveralls category include raw materials, equipment and machinery, labor, facilities and storage, packaging, freight and transportation, and others. Other costs can include testing and inspection, marketing, insurance, tax, overhead expenses, administrative expenses, etc. Medical coveralls are critical for healthcare workers to prevent and control infection. They are designed to provide out-and-out protection from any kind of exposure.  Hence the selection of the fabric or the raw material must be considered carefully. Synthetic fibers such as nylon 6,6, polyester (PET), polypropylene (PP), and polyethylene (PE) are some of the key fabrics considered to manufacture medical or PPE coveralls.

The majority of disposable coveralls are made of synthetic non-woven fabric, which is a single-use material. However, to improve the longevity and range of applications, woven cloth has witnessed some advancements in recent times. Raw materials form the largest cost component in this category. Factors such as the thickness and weight of the fabric, production or order quantity, single-layer or multi-layer structures, and the type of material chosen can further influence the total cost.

Polypropylene is also another cost-effective material that is widely used. In Q3 2023, PP prices in the North American region fluctuated a lot. The start of the third quarter witnessed a 1 - 2% drop in prices owing to a reduction in feedstock PP prices amid inflationary pressure. The continuous inflation forced consumers to reduce their consumption. As a result, demand remained low amid ample supply, which supported the decline. However, at the end of Q3 PP prices increased by 3 - 4% owing to a 5 - 6% rebound increase in feedstock PP prices and a positive demand from the automotive industry. In October 2023, PP prices in the EU region reached EUR 1,393 per MT. This was a 6% increase from September 2023.

In terms of sourcing intelligence, India, China, Malaysia, and Thailand are the most preferred countries to source medical coveralls. In 2022, China was the largest manufacturer of non-woven fabrics. The majority of medical coveralls use nonwoven fabrics. However, production in India has also ramped up steadily since the pandemic. The PPE industry in India has thrived due to low production costs, easy access to raw materials, and zero border restrictions for trade. India’s regulatory framework has significantly improved since 2021 in the PPE industry. It is common for most large end-user organizations to outsource the production of their medical coveralls.

When procuring medical coveralls, it is important to evaluate the suppliers based on product durability, quality, certifications, and protection parameters. Another key sourcing strategy is to ensure that the production process adheres to regulatory requirements and good manufacturing practices (GMP). For instance, the WHO states that the coveralls (or gowns) must meet AAMI-PB70 requirements. Other important regulatory bodies include the American National Standards Institute (ANSI) and the Association of the Advancement of Medical Instrumentation (AAMI). In the case of the raw material or fabrics used, the different standards include ISO 16604, EN 14126 Annex A, ISO 22611, ISO 22612, EN 16604 or ASTM D1238 for testing purposes, AAMI 4 level compliant coverall, etc.

Browse through Grand View Research’s collection of procurement intelligence studies:

• Medical Waste Disposal Procurement Intelligence Report, 2023 - 2030 (Revenue Forecast, Supplier Ranking & Matrix, Emerging Technologies, Pricing Models, Cost Structure, Engagement & Operating Model, Competitive Landscape)

• Medical Writing Procurement Intelligence Report, 2023 - 2030 (Revenue Forecast, Supplier Ranking & Matrix, Emerging Technologies, Pricing Models, Cost Structure, Engagement & Operating Model, Competitive Landscape)

Medical Coveralls Procurement Intelligence Report Scope

• Medical Coveralls Category Growth Rate: CAGR of 7.4% from 2023 to 2030

• Pricing Growth Outlook: 8% - 9% (Annually)

• Pricing Models: Volume-based and contract-based pricing model

• Supplier Selection Scope: Cost and pricing, past engagements, productivity, geographical presence

• Supplier Selection Criteria: Production capacity, type of material (PP, PET, PE), material thickness, sterility, compliance and safety measures, certifications, testing, operational and functional capabilities, technology used, and others

• Report Coverage: Revenue forecast, supplier ranking, supplier positioning matrix, emerging technology, pricing models, cost structure, competitive landscape, growth factors, trends, engagement, and operating model

Key Companies 

• 3M

• Ansell

• Kimberly-Clark Worldwide, Inc.

• Cardinal Health

• O&M Halyard, Inc.

• Lakeland, Inc.

• Derekduck Industries Corp.

• Plasti Surge Industries

• Winner Medical Co., Ltd.

• DuPont de Nemours Inc.

Brief about Pipeline by Grand View Research:

A smart and effective supply chain is essential for growth in any organization. Pipeline division at Grand View Research provides detailed insights on every aspect of supply chain, which helps in efficient procurement decisions.

Our services include (not limited to):

• Market Intelligence involving – market size and forecast, growth factors, and driving trends

• Price and Cost Intelligence – pricing models adopted for the category, total cost of ownerships

• Supplier Intelligence – rich insight on supplier landscape, and identifies suppliers who are dominating, emerging, lounging, and specializing

• Sourcing / Procurement Intelligence – best practices followed in the industry, identifying standard KPIs and SLAs, peer analysis, negotiation strategies to be utilized with the suppliers, and best suited countries for sourcing to minimize supply chain disruptions

[healthcaremarketanalysis]

The global veterinary equipment market in terms of revenue was estimated to be worth $2.2 billion in 2023 and is poised to reach $3.2 billion by 2028, growing at a CAGR of 7.1% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The primary factors driving growth for the veterinary equipment supplies market during the projected period are advancements in veterinary technology, an increase in the population of pets and their owners, increasing demand for livestock veterinary products, rise in the need for pet insurance, an increase in the expense of animal health care, and an increase in the prevalence of diseases in animals.

[trendtrackershq]

Dominance of North America in the Medical Imaging Services Market: Trends, Insights, and Future Prospects

Introduction:

The Medical Imaging Services Market in North America stands at the forefront of global advancements, driven by robust healthcare infrastructure, technological innovation, and strategic investments. This article delves into the factors underpinning North America's dominance in the medical imaging services sector, examining current trends, key players, and future growth opportunities.

Download FREE Sample: https://www.nextmsc.com/medical-imaging-services-market/request-sample

Introduction: North America's Leading Role in Medical Imaging Services

North America, comprising the United States and Canada, commands a significant share of the global medical imaging services market. The region's healthcare landscape is characterized by advanced diagnostic capabilities, widespread adoption of medical imaging technologies, and a strong regulatory framework that promotes innovation and quality in healthcare delivery.

Key Factors Driving Market Dominance

Advanced Healthcare Infrastructure: North America boasts a highly developed healthcare infrastructure with a dense network of hospitals, diagnostic centers, and outpatient facilities. This infrastructure supports the deployment and utilization of state-of-the-art medical imaging equipment, including MRI scanners, CT scanners, ultrasound systems, and PET-CT machines.

Technological Advancements in Imaging Devices: The region leads in technological innovation, continuously upgrading imaging modalities to enhance diagnostic accuracy and patient care. Advanced imaging technologies such as digital mammography, 3D/4D ultrasound, spectral CT, and functional MRI are widely adopted in clinical practice, facilitating precise diagnosis, treatment planning, and therapeutic monitoring.

Strong Research and Development (R&D) Initiatives: North America invests significantly in R&D within the healthcare sector, driving continuous innovation in medical imaging technologies. Research institutions, academic centers, and private enterprises collaborate to develop cutting-edge imaging techniques, AI-powered diagnostics, and software solutions that improve imaging workflow efficiency and clinical outcomes.

High Healthcare Expenditure and Insurance Coverage: The region's high healthcare expenditure per capita and comprehensive insurance coverage contribute to robust demand for medical imaging services. Patients have access to a wide range of imaging modalities and procedures, supported by reimbursement policies that incentivize healthcare providers to invest in advanced imaging capabilities.

Strategic Partnerships and Mergers: Major healthcare providers and imaging equipment manufacturers in North America engage in strategic partnerships, mergers, and acquisitions to expand their service offerings and geographical reach. These collaborations foster innovation, economies of scale, and operational efficiencies in delivering diagnostic imaging services across diverse healthcare settings.

Regulatory Standards and Quality Assurance: Stringent regulatory standards set by agencies such as the Food and Drug Administration (FDA) in the United States ensure the safety, efficacy, and quality of medical imaging devices and services. Compliance with regulatory requirements reinforces trust among healthcare professionals and patients, driving adoption of advanced imaging technologies.

Focus on Value-based Healthcare and Patient Outcomes: There is a growing emphasis on value-based healthcare delivery models that prioritize patient outcomes, cost-effectiveness, and quality of care. Medical imaging plays a pivotal role in early disease detection, treatment optimization, and monitoring disease progression, aligning with value-based care principles that emphasize preventive measures and personalized treatment approaches.

Current Trends in North America's Medical Imaging Services Market

Integration of Artificial Intelligence (AI) and Machine Learning: AI-powered imaging software is transforming radiology practice by enhancing diagnostic accuracy, automating image interpretation, and predicting patient outcomes. AI algorithms analyze vast amounts of imaging data to detect anomalies, quantify disease markers, and support clinical decision-making, thereby improving workflow efficiency and reducing diagnostic errors.

Expansion of Telemedicine and Remote Imaging Services: The COVID-19 pandemic accelerated the adoption of telemedicine and remote imaging services in North America. Tele-radiology platforms enable radiologists to interpret images remotely, collaborate with healthcare teams, and provide timely diagnostic reports to healthcare facilities and patients in diverse geographical locations. Telemedicine solutions enhance access to specialized imaging expertise and streamline patient care delivery.

Shift Towards Value-based Imaging Contracts: Healthcare providers are increasingly adopting value-based imaging contracts that align reimbursement with patient outcomes and quality metrics. Value-based agreements incentivize healthcare organizations and imaging providers to optimize resource utilization, improve diagnostic accuracy, and deliver cost-effective imaging services that enhance patient satisfaction and clinical outcomes.

Emergence of Hybrid Imaging Technologies: Hybrid imaging modalities such as PET-CT, PET-MRI, and SPECT-CT combine anatomical and functional imaging for comprehensive disease assessment. These technologies facilitate precise localization of tumors, accurate staging of cancer, and evaluation of treatment response, driving demand for integrated imaging solutions in oncology, neurology, and cardiology.

Focus on Radiation Dose Reduction and Safety: Continuous advancements in imaging equipment design and software algorithms prioritize patient safety by minimizing radiation exposure during diagnostic procedures. Low-dose imaging techniques, iterative reconstruction algorithms, and dose monitoring technologies ensure optimal image quality while adhering to ALARA (As Low As Reasonably Achievable) principles for radiation protection.

Inquire before buying: https://www.nextmsc.com/medical-imaging-services-market/inquire-before-buying

Regional Insights and Market Dynamics

United States: As the largest market within North America, the United States dominates the medical imaging services sector with its extensive healthcare infrastructure, technological innovation, and high healthcare expenditure. The country's competitive landscape includes leading imaging service providers, academic medical centers, and research-driven hospitals that drive market growth through innovation and quality improvement initiatives.

Canada: Canada's medical imaging services market benefits from universal healthcare coverage, government investments in healthcare infrastructure, and a growing emphasis on digital health technologies. Imaging centers across Canada offer comprehensive diagnostic imaging services, including MRI, CT, ultrasound, and nuclear medicine, to meet the diagnostic needs of its population.

Challenges and Future Outlook

Despite its leadership position, the North American medical imaging services market faces challenges such as healthcare cost containment pressures, regulatory complexities, and workforce shortages in specialized imaging disciplines. Future growth opportunities lie in harnessing digital transformation, expanding telemedicine capabilities, advancing AI-driven diagnostics, and enhancing patient-centric imaging solutions that improve healthcare delivery and clinical outcomes.

Conclusion

North America's dominance in the medical imaging services market reflects its commitment to technological innovation, quality healthcare delivery, and patient-centered care. By leveraging advanced imaging technologies, fostering strategic partnerships, and embracing value-based healthcare models, stakeholders in the region are poised to drive transformative advancements in diagnostic imaging, improve healthcare accessibility, and enhance patient outcomes on a global scale. As the healthcare landscape evolves, continued investment in research, innovation, and regulatory compliance will be essential in sustaining North America's leadership in medical imaging services and shaping the future of healthcare diagnostics worldwide.

[poonamcmi]

Neurodiagnostics Market Estimated to Witness High Growth Owing to Growing Geriatric Population

​The neurodiagnostics market plays a crucial role in neurological disease diagnosis and treatment monitoring. Neurological disorders such as epilepsy, Alzheimer's disease, Multiple Sclerosis, Parkinson's disease, and other neurological conditions are becoming increasingly prevalent. Neurodiagnostics help detect neurological abnormalities through neurological imaging such as MRI, EEG, and diagnostic tests. The growing geriatric population is more susceptible to neurodegenerative diseases, driving the need for neurodiagnostics.

The Global Neurodiagnostics Market is estimated to be valued at US$ 8.66 Bn in 2024 and is expected to exhibit a CAGR of 8.1% over the forecast period 2024 To 2031.

Key Takeaways Key players operating in the neurodiagnostics are Koninklijke Philips N.V, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, FUJIFILM Holdings Corporation, Bio-Rad Laboratories Inc., Advanced Brain Monitoring, Inc., Nihon Kohden Corporation, Mitsar Co. LTD., EMS Biomedical, Mennen Medical, Natus Medical Incorporated, Medicaid Systems, Fujirebio, FONAR Corp, ANT Neuro, NEUROLITE AG, and Atlantic Health System.

The Neurodiagnostics Market Trends  include increasing investments in R&D for biomarker-based disease diagnosis and neuroimaging. The global expansion of key players through mergers and acquisitions will further aid market growth.

The growing geriatric population is more susceptible to neurodegenerative diseases, driving the need for neurodiagnostics. Furthermore, increasing investments in R&D by key players for developing advanced diagnostic systems will boost the neurodiagnostics market over the forecast period.

Market drivers The growing geriatric population is the major driver propelling the Neurodiagnostics Market Size And Trends As per the United Nations, people aged over 60 years are projected to outnumber children under 10 years by 2050. Elderly people are more vulnerable to neurological disorders like Alzheimer's and Parkinson's disease. This will augment the demand for neurodiagnostics for early disease diagnosis and treatment monitoring. Increasing awareness about brain health and availability of reimbursement policies for neurodiagnostic tests will also boost market revenues significantly over the forecast period.

PEST Analysis Political: Regulations related to medical devices and neurological disorder treatments have an impact. Reimbursement policies by governments and insurance agencies also affect market growth. Economic: The growing insurance coverage levels and disposable incomes have boosted healthcare spending including on neurodiagnostics. Higher investments in clinical trials and R&D remain crucial. Social: Rising prevalence of neurological disorders like Alzheimers, Parkinsons, epilepsy, and stroke is a key driver. Growing awareness encourages early diagnosis through imaging techniques. Technological: Advancements in imaging modalities like MRI, CT, PET, EEG, and newer technologies like digital EEG and MEG expands diagnosis capabilities. Portable and wearable devices improve accessibility.

Geographical Regions with High Market Concentration North America accounts for the largest share in the neurodiagnostics market in terms of value, owing to the presence of major players, high healthcare expenditure, and rising neurological disorders. The United States holds a significant share in the regional market.

Fastest Growing Regional Market The Asia Pacific region is expected to witness the highest growth in the neurodiagnostics market during the forecast period. This is attributed to factors such as growing healthcare expenditure, increasing healthcare infrastructure development, and rising geriatric population in the region suffering from neurological conditions. Rapidly developing countries like China and India with huge patient pools offer high growth potential. Get More Insights On, Neurodiagnostics Market About Author: Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)

[secretofresearch]

Veterinary Services Market is Estimated to Witness High Growth

The veterinary services market involves a wide range of important medical services for animals including preventive care, medication, surgeries and other treatment procedures. Regular veterinary exams help monitor animal health and detect problems early. Veterinary professionals also play a key role in disease prevention through vaccination programs. Emerging technologies are revolutionizing veterinary treatment with treatments such as regenerative medicine gaining popularity.

The global veterinary services market is estimated to be valued at US$ 130.16 billion in 2024 and is expected to exhibit a CAGR of 5.0% over the forecast period from 2024 to 2031.

Key Takeaways

Key players operating in the veterinary services are Fagron Sterile Services US, New Drug Loft & VLS Pharmacy, Nora Apothecary, Lifecare Pharmacy, Avella Specialty Pharmacy, Triangle Compounding Pharmacy, O€TMBrien Pharmacy, Tache Pharmacy, Northmark Pharmacy, Edge Pharma, and ImprimisRx. The veterinary services market presents significant opportunities owing to rising pet ownership globally and increasing per capita spending on pet care. Technological advancements are also supporting market growth with emerging therapies such as regenerative medicine gaining popularity for conditions which were earlier untreatable.

The key opportunities in the Veterinary Services Market Demand include rising penetration in developing countries with growing pet adoption, opportunities for multi-specialty services with urbanization and nuclear families, and scope for preventive healthcare programs. Technological innovation is a key enabler in the market with emerging technologies such as regenerative medicines, biologics and stem cell treatment impacting disease management.

Market drivers

One of the key drivers for the veterinary services market is growing pet population globally coupled with rising pet care expenditure. Pet humanization trends have significantly increased spending on pet food, healthcare, insurance and accessories. According to the latest APPA National Pet Owners Survey, U.S. pet industry expenditure reached a record $103.6 billion in 2019, with over $31 billion spent on veterinary care. Growing pet ownership and increasing willingness to spend on pet healthcare is a major market driver.

Current challenges in the Veterinary Services Market:

The veterinary services market is facing several challenges currently. One of the major challenges is the shortage of veterinarians globally. There is currently an unmet demand for veterinary care due to lack of sufficient veterinary professionals. This leads to delay in delivery of care. Another challenge is rising veterinary care costs. The costs associated with veterinary medicine and surgeries have increased significantly over the years. This pressure on budgets restricts access to quality care for many pet owners. Lack of awareness among pet owners regarding veterinary preventive healthcare is also a challenge. Many pet owners only seek treatment when their pet falls sick rather than focusing on preventive healthcare checkups. This affects timely diagnosis and treatment.

SWOT Analysis

Strength: Strong bond between veterinarians and pet owners leads to loyalty; Growing pet humanization trend boosts demand.

Weakness: Shortage of vets causes delay in care; Higher costs restrict broader access to care.

Opportunity: Rising pet adoption during COVID drives future growth; Scope for preventive healthcare awareness programs.

Threats: Threat from illegal or unqualified Veterinary Services Market Analysis offering low-cost services; Risk of new pet diseases and virus outbreaks.

Geographical Regions

North America dominated the veterinary services market in terms of value in the historical period due to high pet ownership and growing expenditure on pet care in countries like the US and Canada. Asia Pacific is expected to be the fastest growing region during the forecast period driven by factors like rising affluence, nuclearization of families and increasing awareness about animal health in major countries.

The United States represents the most concentrated geographical region for the veterinary services market currently. Within the country, states like California, Texas and New York have emerged as major hubs for both veterinary practices and companion animal care expenditures. Other developed countries within North America and Western Europe also exhibit high demand density due to high pet ownership.

Get more insights on Veterinary Services Market

About Author:

Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.

(LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91)

[prajwal-agale001]

According to Meticulous Research®, the pet oral care market is set to reach $3 billion by 2030, growing at a CAGR of 6.1% during the forecast period. This growth is fueled by increasing pet ownership and population, rising pet expenditure and insurance, and the growing incidence of dental diseases in pets. The market is segmented by product types (such as toothpaste, toothbrushes, mouthwash, dental chews, and additives), animal type (dogs and cats), sales channels (including online platforms and offline stores like pet shops, supermarkets, and pharmacies), and geography. The study also assesses industry competitors and their market share on both global and regional scales.